Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MHLW Report Finds No Relations Between Tamiflu Use And Abnormal Behavior

This article was originally published in PharmAsia News

Executive Summary

A safety team at Japan's Ministry of Health, Labor and Welfare reported June 17 that clinical tests found no evidence that taking Chugai Pharmaceutical's flu drug Tamiflu (oseltamivir phosphate) affected electrocardiograms and sleep patterns. The clinical report also stated that there was no evidence showing relation between the administration of Tamiflu and sudden death or abnormal behavior. The team conducted electrocardiograms on 11 healthy males between the ages of 20-51. The team also conducted researches on brain waves of 31 males aged between 20-24 when sleeping and found no abnormality in brain waves after taking Tamiflu. (Click here for more - Japanese language

You may also be interested in...



SUNSET Draft Rule Is Trump Admin’s ‘Latest Attempt To Sabotage HHS Programs,’ Analyst Charges

The proposed rule from the US HHS that would require its agencies to review all regulations every 10 years could distract an incoming Biden administration from the COVID-19 pandemic and will “wreak havoc” on Medicare, a senior policy analyst for the Center on Budget and Policy Priorities says.

CVS CEO Merlo On COVID-19 Vaccination: "Think Of It Like Booking A Travel Ticket"

The pharmacy will be ready to begin COVID-19 vaccinations 48 hours after receiving the vaccine, Merlo said, outlining plans for a mass vaccination effort that will include online appointments.

Cosmetic And Personal Trademark Review 1 December, 2020

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

UsernamePublicRestriction

Register

SC143406

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel